David A. Gonyer's most recent trade in Evoke Pharma Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | David A. Gonyer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 415,000 | 415,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | David A. Gonyer | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.90 per share. | 11 Dec 2020 | 48,046 | 363,736 (1%) | 0% | 2.9 | 139,333 | Common Stock |
| Evoke Pharma Inc | David A. Gonyer | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 11 Dec 2020 | 23,954 | 339,782 (1%) | 0% | 2.9 | 70,425 | Common Stock |
| Evoke Pharma Inc | David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 1.05 per share. | 01 Sep 2020 | 20,238 | 339,782 (1%) | 0% | 1.1 | 21,250 | Common Stock |